[1] Miller MD, Salinas EA, Newtson AM, et al. An integrated prediction model of recurrence in endometrial endometrioid cancers. Cancer Manag Res. 2019;11:5301-15.
[2] De Boer SM, Nout RA, Bosse T, Creutzberg CL. Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directions. Expert Rev Anticancer Ther. 2019;19(1):51-60.
[3] Liu Y, Zhao R, Chi S, et al. Is Upregulated by Estrogen and Promotes Epithelial-Mesenchymal Transition via p53 in Endometrial Cancer. Mol Cancer Res. 2020;18(2):204-15.
[4] Emura N, Wang C-M, Yang WH, Yang W-H. Steroidogenic Factor 1 (NR5A1) Activates ATF3 Transcriptional Activity. Int J Mol Sci. 2020;21(4).
[5] Hammer GD, Ingraham HA. Steroidogenic factor-1: its role in endocrine organ development and differentiation. Front Neuroendocrinol. 1999;20(3):199-223.
[6] Wong M, Ikeda Y, Luo X, et al. Steroidogenic factor 1 plays multiple roles in endocrine development and function. Recent Prog Horm Res. 1997;52.
[7] Lichtenauer UD, Duchniewicz M, Kolanczyk M, et al. Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. Endocrinology. 2007;148(2):693-704.
[8] Sekiya A, Takasawa K, Arai Y, Torisu S, Nishino K. Dog Steroidogenic Factor-1: Molecular cloning and analysis of epigenetic regulation. J Vet Med Sci. 2020;82(6):681-9.
[9] Figueiredo BC, Cavalli LR, Pianovski MAD, et al. Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J Clin Endocrinol Metab. 2005;90(2):615-9.
[10] Zhong Q, Fan J, Chu H, et al. Integrative analysis of genomic and epigenetic regulation of endometrial cancer. Aging (Albany NY). 2020;12(10):9260-74.
[11] Kommoss FKF, Stichel D, Schrimpf D, et al. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics. J Cancer Res Clin Oncol. 2020;146(1).
[12] van den Helder R, Wever BMM, van Trommel NE, et al. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine. Clin Epigenetics. 2020;12(1):165.
[13] De Smet C, Loriot A. DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey. Epigenetics. 2010;5(3):206-13.
[14] Hoivik EA, Bjanesoy TE, Mai O, et al. DNA methylation of intronic enhancers directs tissue-specific expression of steroidogenic factor 1/adrenal 4 binding protein (SF-1/Ad4BP). Endocrinology. 2011;152(5):2100-12.
[15] Matsukura H, Aisaki K-i, Igarashi K, et al. Genistein promotes DNA demethylation of the steroidogenic factor 1 (SF-1) promoter in endometrial stromal cells. Biochem Biophys Res Commun. 2011;412(2):366-72.
[16] Skvortsova K, Stirzaker C, Taberlay P. The DNA methylation landscape in cancer. Essays Biochem. 2019;63(6):797-811.
[17] Tao MH, Freudenheim JL. DNA methylation in endometrial cancer. Epigenetics. 2010;5(6):491-8.
[18] Luo X, Ikeda Y, Parker KL. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell. 1994;77(4):481-90.
[19] Val P, Lefrançois-Martinez A-M, Veyssière G, Martinez A. SF-1 a key player in the development and differentiation of steroidogenic tissues. Nucl Recept. 2003;1(1):8.
[20] Almeida MQ, Soares IC, Ribeiro TC, et al. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. J Clin Endocrinol Metab. 2010;95(3):1458-62.
[21] Doghman M, Karpova T, Rodrigues GA, et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol. 2007;21(12):2968-87.
[22] Xue Q, Zhou YF, Zhu SN, Bulun SE. Hypermethylation of the CpG island spanning from exon II to intron III is associated with steroidogenic factor 1 expression in stromal cells of endometriosis. Reprod Sci. 2011;18(11):1080-4.
[23] Xue Q, Xu Y, Yang H, et al. Methylation of a novel CpG island of intron 1 is associated with steroidogenic factor 1 expression in endometriotic stromal cells. Reprod Sci. 2014;21(3):395-400.
[24] Marquardt RM, Kim TH, Shin J-H, Jeong J-W. Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis? Int J Mol Sci. 2019;20(15).
[25] Zhou W-J, Zhang J, Yang H-L, et al. Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism. Cell Commun Signal. 2019;17(1):99.
[26] Jiang P, Huang J, Deng Y, et al. Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers. Cancer Manag Res. 2020;12:7395-403.
[27] Lyko F. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation. Nat Rev Genet. 2018;19(2):81-92.
[28] Tajima S, Suetake I, Takeshita K, Nakagawa A, Kimura H. Domain Structure of the Dnmt1, Dnmt3a, and Dnmt3b DNA Methyltransferases. Adv Exp Med Biol. 2016;945:63-86.
[29] Chen Z, Zhang Y. Role of Mammalian DNA Methyltransferases in Development. Annu Rev Biochem. 2020;89:135-58.
[30] Liang G, Weisenberger DJ. DNA methylation aberrancies as a guide for surveillance and treatment of human cancers. Epigenetics. 2017;12(6):416-32.
[31] Lucki NC, Li D, Bandyopadhyay S, Wang E, Merrill AH, Sewer MB. Acid ceramidase (ASAH1) represses steroidogenic factor 1-dependent gene transcription in H295R human adrenocortical cells by binding to the receptor. Mol Cell Biol. 2012;32(21):4419-31.